Cytometry Part B-Clinical Cytometry

Papers
(The TQCC of Cytometry Part B-Clinical Cytometry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue highlights—January 202531
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells30
29
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring27
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease23
Issue highlights—September 202318
17
Issue Information16
15
Standardization of flow cytometric detection of antigen expression14
Issue Information14
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma12
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa12
Issue Information11
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients11
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel11
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis11
Issue Highlights—January 202210
Issue Information10
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia10
CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes10
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia9
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow 9
ROR1 expression in mature B lymphoid neoplasms by flow cytometry9
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric9
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR9
Issue Information9
Issue Information9
9
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry8
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT8
SingletSeeker: an unsupervised clustering approach for automated singlet discrimination in cytometry8
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International 7
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays7
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia7
6
Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry6
Issue Information6
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry6
Bone marrow follicular‐like T cells in monoclonal gammopathies6
6
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis6
5
Editorial on IVD cellular assay validation5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
Possible alternative strategies to implement basophil activation testing in multicentric studies5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening5
Issue Highlights—July 20224
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup4
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry4
Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA‐DR expression in clinical samples4
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet4
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care4
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases4
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD74
Use of flow cytometry and cytology to differentiate breast implant‐associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients3
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia3
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis3
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis3
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome3
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry3
Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study3
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern3
Issue highlights—July 20243
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia3
3
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition3
3
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent3
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions3
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease3
Issue Highlights—November 20213
Issue highlights—November 20243
3
Issue Highlights—March 20223
0.051172018051147